Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case–control study

INTRODUCTION: In 2006, the first human papillomavirus (HPV) vaccine was approved by the Food and Drug Administration in the USA based on pre-licensure clinical trials that found it to be highly efficacious at preventing persistent infection and precancerous, high-grade cervical lesions (HGCLs) cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Carlos R, Ortiz, Anette Michelle, Sheth, Sangini S, Shapiro, Eugene D, Niccolai, Linda M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057558/
https://www.ncbi.nlm.nih.gov/pubmed/33875441
http://dx.doi.org/10.1136/bmjopen-2020-043093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057558/
https://www.ncbi.nlm.nih.gov/pubmed/33875441
http://dx.doi.org/10.1136/bmjopen-2020-043093

Ejemplares similares